Please assess the completion status of the following clinical trial:

Trial Title: Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 to 65 years~* Fever, respiratory symptoms and constitutional symptoms compatible with influenza infection~* Influenza A or B infection in the local community~* Onset of illness no more than 48 hours before presentation~* Willing and able to provide comply with protocol requirements~Exclusion Criteria:~* Severity of illness requiring or anticipated to require in-hospital care~* High risk of complications from influenza per IDSA (Infectious Diseases Society of America) guidelines or current CDC (Centers for Disease Control) criteria~* Females pregnant, breast-feeding or sexually active without birth control~* Vaccination for seasonal influenza or H1N1 on or after August 1, 2009~* Treatment with antiviral medication for influenza within 1 month prior to screening~* Treatment with nitazoxanide or any investigational drug within 1 month prior to screening~* Known sensitivity to nitazoxanide or any excipients~* Unable to take oral medications~* Chronic kidney or liver disease or known impaired hepatic and/or renal function~* Other pre-existing chronic infection undergoing or requiring medical therapy~* Pre-existing illness placing subject at unreasonably increased risk by participation in study~* Unlikely to comply with the requirements of this protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Nitazoxanide (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).